Niacin Bests Ezetimibe as Add-On Therapy, Johns Hopkins University School of Medicine Researchers Say

MedPage Today -- ORLANDO -- Boosting HDL cholesterol with extended-release niacin (Niaspan) is a more effective way of slowing atherosclerosis in high-risk patients on long-term statin therapy than seeking additional LDL cholesterol reductions by adding ezetimibe (Zetia), researchers here reported.